Morgan Stanley’s Zosano Pharma Corporation ZSAN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-3,399
| Closed | -$27K | – | 8306 |
|
|
2022
Q1 | $27K | Buy |
3,399
+1,289
| +61% | +$10.2K | ﹤0.01% | 7019 |
|
|
2021
Q4 | $34K | Buy |
2,110
+1,045
| +98% | +$16.8K | ﹤0.01% | 6990 |
|
|
2021
Q3 | $27K | Hold |
1,065
| – | – | ﹤0.01% | 6985 |
|
|
2021
Q2 | $35K | Sell |
1,065
-246
| -19% | -$8.09K | ﹤0.01% | 6810 |
|
|
2021
Q1 | $57K | Buy |
1,311
+1,187
| +957% | +$51.6K | ﹤0.01% | 6300 |
|
|
2020
Q4 | $2K | Sell |
124
-36,056
| -100% | -$582K | ﹤0.01% | 6917 |
|
|
2020
Q3 | $2.05M | Buy |
36,180
+35,885
| +12,164% | +$2.04M | ﹤0.01% | 3634 |
|
|
2020
Q2 | $9K | Sell |
295
-39
| -12% | -$1.19K | ﹤0.01% | 6200 |
|
|
2020
Q1 | $7K | Buy |
334
+77
| +30% | +$1.61K | ﹤0.01% | 6134 |
|
|
2019
Q4 | $14K | Buy |
+257
| New | +$14K | ﹤0.01% | 6193 |
|
|
2019
Q2 | – | Sell |
-7,679
| Closed | -$1.28M | – | 6828 |
|
|
2019
Q1 | $1.28M | Buy |
7,679
+2,111
| +38% | +$352K | ﹤0.01% | 3943 |
|
|
2018
Q4 | $413K | Hold |
5,568
| – | – | ﹤0.01% | 4903 |
|
|
2018
Q3 | $797K | Buy |
5,568
+805
| +17% | +$115K | ﹤0.01% | 4700 |
|
|
2018
Q2 | $680K | Buy |
4,763
+3,972
| +502% | +$567K | ﹤0.01% | 4889 |
|
|
2018
Q1 | $139K | Buy |
791
+507
| +179% | +$89.1K | ﹤0.01% | 5615 |
|
|
2017
Q4 | $104K | Sell |
284
-57
| -17% | -$20.9K | ﹤0.01% | 5624 |
|
|
2017
Q3 | $196K | Sell |
341
-100
| -23% | -$57.5K | ﹤0.01% | 5365 |
|
|
2017
Q2 | $435K | Buy |
441
+28
| +7% | +$27.6K | ﹤0.01% | 4893 |
|
|
2017
Q1 | $550K | Buy |
+413
| New | +$550K | ﹤0.01% | 4774 |
|
|
2015
Q2 | – | Sell |
-20
| Closed | -$143K | – | 6810 |
|
|
2015
Q1 | $143K | Buy |
+20
| New | +$143K | ﹤0.01% | 5373 |
|